Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Lone Tree, CO
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Lone Tree, CO
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Jacksonville, FL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Miami, FL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Naples, FL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Arlington Heights, IL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Urbana, IL
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Urbana, IL
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Hammond, LA
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Hammond, LA
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Chesterfield, MI
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Chesterfield, MI
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Rochester, MN
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Great Neck, NY
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
New York, NY
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Charlotte, NC
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Greenville, NC
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Mentor, OH
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Mentor, OH
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Germantown, TN
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
San Antonio, TX
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Seattle, WA
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Seattle, WA
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  11/17/2017
Research Site
mi
from
Bankstown,
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Research Site
mi
from
Bankstown,
Click here to add this to my saved trials
TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Study 0146: A Phase 1a, Double-Blinded, Randomized, Placebo Controlled, Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, and Systemic Exposure of TD−3504 in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  12/1/2017
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Study 0146: A Phase 1a, Double-Blinded, Randomized, Placebo Controlled, Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, and Systemic Exposure of TD−3504 in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 12/1/2017
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort
Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort - APRIL Cohort
Status: Enrolling
Updated:  12/5/2017
University of North Carolina at Chapel Hill- CGIBD
mi
from
Chapel Hill, NC
Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort
Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort - APRIL Cohort
Status: Enrolling
Updated: 12/5/2017
University of North Carolina at Chapel Hill- CGIBD
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
First Care Family Doctors South
mi
from
Fayetteville, AR
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
First Care Family Doctors South
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Little Rock Diagnostic Clinic
mi
from
Little Rock, AR
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Little Rock Diagnostic Clinic
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
AGMG Clinical Research
mi
from
Anaheim, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
AGMG Clinical Research
mi
from
Anaheim, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Lovelace Scientific Resources
mi
from
Beverly Hills, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Lovelace Scientific Resources
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Digestive Liver Disease Specialists, Medical Group
mi
from
Garden Grove, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Digestive Liver Disease Specialists, Medical Group
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Long Beach VA Medical Center
mi
from
Long Beach, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Long Beach VA Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Community Clinical Trials
mi
from
Orange, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Community Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Rider Research Group
mi
from
San Francisco, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Rider Research Group
mi
from
San Francisco, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
John Jolley, M.D.
mi
from
San Rafael, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
John Jolley, M.D.
mi
from
San Rafael, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Lovelace Scientific Resources
mi
from
Santa Ana, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Lovelace Scientific Resources
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Santa Barbara Clinical Research
mi
from
Santa Barbara, CA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Santa Barbara Clinical Research
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Professionals for Clinical Research
mi
from
Littleton, CO
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Professionals for Clinical Research
mi
from
Littleton, CO
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Connecticut Gastroenterology Institute
mi
from
Bristol, CT
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Connecticut Gastroenterology Institute
mi
from
Bristol, CT
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Clinical Research of Tampa Bay, Inc.
mi
from
Brooksville, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Clinical Research of Tampa Bay, Inc.
mi
from
Brooksville, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Medical Research Unlimited
mi
from
Hialeah, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Medical Research Unlimited
mi
from
Hialeah, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Southern Clinical Research Consultants
mi
from
Hollywood, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Southern Clinical Research Consultants
mi
from
Hollywood, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
United Medical Research
mi
from
New Smyrna Beach, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
United Medical Research
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Venture Research Institute, LLC
mi
from
North Miami Beach, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Venture Research Institute, LLC
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Penninsula Research, Inc.
mi
from
Ormond Beach, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Penninsula Research, Inc.
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Advanced Gastroenterology Associates, LLC
mi
from
Palm Harbor, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Advanced Gastroenterology Associates, LLC
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Lovelace Scientific Resources
mi
from
Sarasota, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Lovelace Scientific Resources
mi
from
Sarasota, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Advent Clinical Research
mi
from
Sarasota, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Advent Clinical Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Metabolic Research Institute, Inc.
mi
from
West Palm Beach, FL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Metabolic Research Institute, Inc.
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Consultative Gastroenterology
mi
from
Atlanta, GA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Consultative Gastroenterology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Digestive Care Associates
mi
from
Austell, GA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Digestive Care Associates
mi
from
Austell, GA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Center for Gastroenterology
mi
from
Decatur, GA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Center for Gastroenterology
mi
from
Decatur, GA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials